SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-22-000061
Filing Date
2022-05-09
Accepted
2022-05-09 08:00:36
Documents
20
Period of Report
2022-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20220509.htm   iXBRL 8-K 40657
2 EX-99.1 ex991_20220509x1q2022ear.htm EX-99.1 19406
6 ex991_20220509x1q2022ear001.jpg GRAPHIC 247846
7 ex991_20220509x1q2022ear002.jpg GRAPHIC 267867
8 ex991_20220509x1q2022ear003.jpg GRAPHIC 318792
9 ex991_20220509x1q2022ear004.jpg GRAPHIC 328608
10 ex991_20220509x1q2022ear005.jpg GRAPHIC 206109
11 ex991_20220509x1q2022ear006.jpg GRAPHIC 119948
12 ex991_20220509x1q2022ear007.jpg GRAPHIC 94135
  Complete submission text file 0001485003-22-000061.txt   2390304

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20220509.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20220509_lab.xml EX-101.LAB 24993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20220509_pre.xml EX-101.PRE 13190
14 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20220509_htm.xml XML 11816
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 22903287
SIC: 2834 Pharmaceutical Preparations